 |
|
GdCl3 |
| Product |
Product Code |
Order or Specifications |
99% Gadolinium Chloride Solution |
|
 |
99.9% Gadolinium Chloride Solution |
GD-CL-03-SOL |
 |
99.99% Gadolinium Chloride Solution |
GD-CL-04-SOL |
 |
99.999% Gadolinium Chloride Solution |
|
 |
|
Gadolinium Chloride Solutions are moderate to highly concentrated liquid solutions of Gadolinium Chloride. They are an excellent source of Gadolinium Chloride for applications requiring solubabilzed materials. American Elements can prepare dissolved homogenous solutions at customer specified concentrations or to the maximum stoichiometric concentration. Packaging is available in 55 gallon drums, smaller units and larger liquid totes. American Elements maintains solution production facilities in the United States, Northern Europe (Liverpool, UK), Southern Europe (Milan, Italy), Australia and China to allow for lower freight costs and quicker delivery to our customers .American Elements metal and rare earth compound solutions have numerous applications, but are commonly used in petrochemical cracking and automotive catalysts, water treatment, plating, textiles, research and in optic, laser, crystal and glass applications. Ultra high purity and high purity compositions improve both optical quality and usefulness as scientific standards. Nanoscale (See also Nanotechnology Information and Quantum Dots) elemental powders and suspensions, as alternative high surface area forms, may be considered. We also produce Gadolinium Chloride. Additional technical, research and safety (MSDS) information is available as is a Reference Calculator for converting relevant units of measurement.
Gadolinium is a Block F, Group 3, Period 6 element. The electronic configuration is [Xe]4f75d16s2. In its elemental form gadolinium's CAS number is 7440-54-2. The gadolinium atom has a radius of 178.7.pm and it's Van der Waals radius is unknown. Gadolinium is utilized for both its high magnetic moment (7.94µB) and in phosphors and scintillator material. When complexed with EDTA ligands, it is used as an injectable contrast agent for patients undergoing magnetic resonance imaging. Gadolinium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder.
|
| Formula |
CAS No. |
Appearance |
Molecular Weight |
| GdCl3 |
13450-84-5 |
White to Clear Liquid |
263.61 |
|
|
© 2001-2008. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements. |
|
|
Recent Research & Development for Gadolinium
-
Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma.
Abdom Imaging. 2007 Oct 3; [Epub ahead of print]
- In vivo Imaging of the Systemic Recruitment of Fibroblasts to the Angiogenic Rim of Ovarian Carcinoma Tumors.
Cancer Res. 2007 Oct 1;67(19):9180-9.
- Evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritis.
Arthritis Rheum. 2007 Sep 28;56(10):3496-3501 [Epub ahead of print]
- Nephrogenic systemic fibrosis and gadolinium exposure: Association and lessons for idiopathic fibrosing disorders.
Arthritis Rheum. 2007 Sep 28;56(10):3173-3175 [Epub ahead of print] No abstract available.
- Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposure.
Arthritis Rheum. 2007 Sep 28;56(10):3433-3441 [Epub ahead of print]
- Gadolinium:Nonionic Contrast Media (1:1) Coronary Angiography in Patients With Impaired Renal Function.
Angiology. 2007 Sep 28; [Epub ahead of print]
- Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents.
Cancer Imaging. 2007 Sep 24;7(1):130-137.
- 3-Dimensional magnetic resonance genitography: a different look at cloacal malformations.
J Urol. 2007 Oct;178(4 Pt 2):1675-8; discussion 1678-9. Epub 2007 Aug 17.
- Spontaneous intracranial hypotension: a cause of severe acute headache.
Emerg Med J. 2007 Oct;24(10):739-41.
- Influence of Kupffer cell inactivation on cycloheximide-induced hepatic injury.
Toxicology. 2007 Aug 25; [Epub ahead of print]
- Intraosseous pilomatricoma: a possible rare skeletal manifestation of Gardner syndrome.
Skeletal Radiol. 2007 Jan 18; [Epub ahead of print]
- Cavernous hemangioma of the internal auditory canal.
Eur Arch Otorhinolaryngol. 2007 Jan 18; [Epub ahead of print]
- Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats.
J Control Release. 2006 Nov 11; [Epub ahead of print]
- Receptor-mediated internalization of chelator-PNA-peptide hybridization probes for radioimaging or magnetic resonance imaging of oncogene mRNAs in tumours.
Biochem Soc Trans. 2007 Feb;35(Pt 1):72-6.
- Gadolinium periconceptional exposure: pregnancy and neonatal outcome.
Acta Obstet Gynecol Scand. 2007;86(1):99-101.
- MRI contrast agents may pose risk for patients with kidney disease.
JAMA. 2007 Jan 17;297(3):252-3. No abstract available.
- Clear Cell Sarcoma of Tendons and Aponeuroses: A Review.
Arch Pathol Lab Med. 2007 Jan 1;131(1):152 [Epub ahead of print]
- On the role of the counter-ion in defining water structure and dynamics: order, structure and dynamics in hydrophilic and hydrophobic gadolinium salt complexes.
Dalton Trans. 2006 Dec 21;(47):5605-16. Epub 2006 Aug 25.
- Magnetic resonance imaging findings associated with surgically proven rotator interval lesions.
Skeletal Radiol. 2007 Jan 16; [Epub ahead of print]
- Inflammatory synovitis due to underlying lipoma arborescens (gadolinium-enhanced MRI features): report of two cases.
Clin Rheumatol. 2007 Jan 16; [Epub ahead of print]
|
|